Management of Cluster Headache

@article{TfeltHansen2012ManagementOC,
  title={Management of Cluster Headache},
  author={Peer Tfelt-Hansen and Rigmor H{\o}jland Jensen},
  journal={CNS Drugs},
  year={2012},
  volume={26},
  pages={571-580},
  url={https://api.semanticscholar.org/CorpusID:22522914}
}
The relatively short-lasting attack of pain in one eye with typical associated symptoms should lead the family doctor to suspect cluster headache resulting in a referral to a neurologist or a headache centre with experience in the treatment of cluster headache.

Cluster Headache in Childhood

Steroids showed a good clinical efficacy in interrupting cluster headache recurrence and acetaminophen as well as ibuprofen were ineffective; indomethacin was effective in 1 case.

Pharmacotherapy of cluster headache

In most cases, cluster headache can be treated sufficiently by an individual concept of acute and prophylactic drug treatment and new anticonvulsants and unconventional ways of immunotherapy should be evaluated.

Cluster headache attack remission with sphenopalatine ganglion stimulation: experiences in chronic cluster headache patients through 24 months

In this population of 33 refractory CCH patients, neuromodulation of the SPG induced periods of remission from cluster attacks in a subset of these, and some patients experiencing remission were also able to reduce or stop their preventive medication and remissions were accompanied by an improvement in headache disability.

Real-life treatment of cluster headache in a tertiary headache center – results from the Danish Cluster Headache Survey

Episodic cluster headache is more responsive to acute therapy than chronic and sumatriptan injection was more effective than oxygen and the responder-rate was limited with verapamil.

Exercise as a Promising Strategy to Manage Cluster Headache Pain: A Case Report

Performing moderate-intensity aerobic exercise at the onset of a cluster headache attack may be an interesting non-pharmacologic intervention that can be used to ease pain symptoms.

Triptans for acute cluster headache.

Subcutaneous sumatriptan 6 mg was superior to intranasal zolmitriptan 5 mg or 10 mg for rapid (15 minute)responses, which are important in this condition, and Oral routes of administration are not appropriate.

Management of chronic headache.

This article provides a review of headache presentation and management, with an emphasis on chronic headaches and the differentiation between migraine and tension-type headache (TTH).

Patient satisfaction with conventional, complementary, and alternative treatment for cluster headache in a Norwegian cohort

About two-thirds of cluster headache patients were satisfied with treatment from either GPs or neurologists, and about one-third had used CAM.

Acute, transitional and long-term cluster headache treatment: pharmacokinetic issues

This work focused on how clinically significant pharmacokinetic drug-drug and food-drug interactions can be carefully managed both in cluster headache patients with a progressive frequency of bouts and in chronic cluster headache sufferers.

Occipital Injections for Trigemino-Autonomic Cephalalgias: Evidence and Uncertainties

The evidence supports the use of injected steroids, with or without the addition of an anesthetic, and can be used as an adjunct to an oral prophylactic for a quicker improvement in cluster headache management.

Treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients

Improvement occurred within days to weeks for those who responded most and patients consistently reported their attacks returned within hours to days when the device was off and one patient found that ONS helped abort acute attacks.

Medication-overuse headache in patients with cluster headache

Patients with CH, especially those with a personal and/or family history of migraine, must be carefully monitored for MOH, and medication withdrawal should be considered if a CH patient presents with features of MOH.

Medication-overuse headache in patients with cluster headache

Medication-overuse headache is a previously underrecognized and treatable problem associated with cluster headache (CH).

EFNS guidelines on the treatment of cluster headache and other trigeminal‐autonomic cephalalgias

Large series suggest that lamotrigine is the most effective preventive agent, with topiramate and gabapentin also being useful in treatment of SUNCT syndrome, and surgical procedures, although in part promising, require further scientific evaluation.

Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study.

Five-milligram and 10-mg doses of zolmitriptan intranasal spray are effective within 30 minutes and well tolerated in the treatment of acute cluster headache.

Treatment costs and indirect costs of cluster headache: A health economics analysis

Cluster headache leads to major socioeconomic impact on patients as well as society due to direct healthcare costs and indirect costs caused by loss of working capacity and direct costs due to healthcare utilisation.

High-flow oxygen for treatment of cluster headache: a randomized trial.

Treatment of patients with cluster headache at symptom onset using inhaled high-flow oxygen compared with placebo was more likely to result in being pain-free at 15 minutes.

Towards a Definition of Intractable Headache for Use in Clinical Practice and Trials

The definition of intractability is explored to provide some standard against which to test new treatments for patients, who have been called intractable and do not respond to regulatory-approved and other conventional preventive therapies.

Burden of Cluster Headache

Cluster headache, although periodic in most cases, has considerable impact on social functions, quality of life and use of healthcare.